Severity of clinical dry eye manifestations influences protein expression in tear fluid of patients with primary Sjögren’s syndrome

• Published in: PloS one Vol. 13; no. 10; p. e0205762
• Main Authors: Aqrawi, Lara A., Chen, Xiangjun, Jensen, Janicke Liaaen, Morthen, Mathias Kaurstad, Thiede, Bernd, Utheim, Øygunn Aass, Palm, Øyvind, Tashbayev, Behzod, Utheim, Tor Paaske, Galtung, Hilde Kanli
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 2018; Public Library of Science (PLoS)
• Subjects: Aconitate hydratase; Adaptive immunity; Arthritis; Biochemistry; Bioindicators; Biology and Life Sciences; Biomarkers; Chromatography; Cornea; Data processing; Dentistry; Deoxyribonucleic acid; Diagnostic systems; DNA; Eye; Eye diseases; Fluids; Hospitals; Immunity; Inflammation; Liquid chromatography; Mass spectrometry; Mass spectroscopy; Medicine; Medicine and Health Sciences; Osmolarity; Patients; Peroxidase; Protein expression; Proteins; Proteomes; Proteomics; Reductase; Rheumatic diseases; Rheumatology; Scientific imaging; Sensitivity analysis; Sjogren's syndrome; Surgery; Tearing; Thioredoxin; Norway
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0205762

Ocular dryness is a characteristic feature of primary Sjögren's syndrome (pSS). This may result in dry eye disease (DED), leading to damage of the ocular surface. Additional, non-invasive diagnostic techniques are needed when evaluating pSS patients. Hence, screening for disease-specific biomarkers in biological fluid could be promising. We have previously examined the proteome of tear fluid from pSS patients through Liquid chromatography-mass spectrometry (LC-MS), and conducted a thorough ocular evaluation of patients with pSS. In this study we further explored the association between dry eye manifestations and protein expression in tear fluid of pSS patients. Medical history of 27 patients and 32 healthy controls was gathered. Subjective complaints were registered through questionnaires. Objective findings including tear osmolarity, tear film break up time (TFBUT), Schirmer's test, and ocular and corneal surface staining were also recorded. LC-MS was conducted formerly on tear fluid from all subjects in order to generate proteomic biomarker profiles. Scaffold was employed to analyse the LC-MS data for quantitative differences between patient and control groups, and the mean spectral counts were calculated for the five most upregulated proteins in relation to DED manifestations. Dysregulated cellular processes were identified in pSS patients using FunRichv3 enrichment analysis. The five most upregulated proteins previously identified in pSS patients were DNA (apurinic or apyrimidinic site) lyase (APEX1), thioredoxin-dependent peroxidase reductase (PRDX3), copine (CPNE1), aconitate hydratase (ACO2), and LIM domain only protein 7 (LMO7), in descending order. A significant increase in mean spectral counts for these proteins were observed in pSS patients with pathological DED manifestations compared to healthy controls (p<0.0001). Consequently, dysregulated cellular pathways involving innate and adaptive immunity were also detected. In conclusion, our observations suggest a relationship between presence of dry eye signs and upregulated proteins in tear fluid from patients with pSS. Further studies are needed in order to replicate the concepts explored and analyses performed in a greater cohort of pSS patients, where sensitivity and specificity of the methods conducted can also be verified further.